nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—ABCB1—Lisinopril—systemic scleroderma	0.037	0.189	CbGbCtD
Aripiprazole—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0335	0.171	CbGbCtD
Aripiprazole—ABCB1—Captopril—systemic scleroderma	0.0277	0.141	CbGbCtD
Aripiprazole—HTR2B—cardial valve—systemic scleroderma	0.0268	0.16	CbGeAlD
Aripiprazole—CYP2D6—Captopril—systemic scleroderma	0.0261	0.133	CbGbCtD
Aripiprazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0218	0.111	CbGbCtD
Aripiprazole—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0203	0.121	CbGeAlD
Aripiprazole—ABCB1—Prednisone—systemic scleroderma	0.0174	0.089	CbGbCtD
Aripiprazole—HTR7—myenteric nerve plexus—systemic scleroderma	0.0131	0.0783	CbGeAlD
Aripiprazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0131	0.0667	CbGbCtD
Aripiprazole—CYP3A4—Prednisone—systemic scleroderma	0.0105	0.0533	CbGbCtD
Aripiprazole—HTR7—pulmonary artery—systemic scleroderma	0.0093	0.0554	CbGeAlD
Aripiprazole—ABCB1—Methotrexate—systemic scleroderma	0.00875	0.0447	CbGbCtD
Aripiprazole—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00819	0.0488	CbGeAlD
Aripiprazole—HTR2A—pulmonary artery—systemic scleroderma	0.0058	0.0346	CbGeAlD
Aripiprazole—HTR1B—artery—systemic scleroderma	0.00447	0.0266	CbGeAlD
Aripiprazole—HTR1D—artery—systemic scleroderma	0.00433	0.0258	CbGeAlD
Aripiprazole—HTR1B—blood vessel—systemic scleroderma	0.00348	0.0207	CbGeAlD
Aripiprazole—HTR7—artery—systemic scleroderma	0.00345	0.0205	CbGeAlD
Aripiprazole—HTR1D—blood vessel—systemic scleroderma	0.00337	0.0201	CbGeAlD
Aripiprazole—HTR7—endothelium—systemic scleroderma	0.00291	0.0174	CbGeAlD
Aripiprazole—HTR7—blood vessel—systemic scleroderma	0.00269	0.016	CbGeAlD
Aripiprazole—CHRM5—skin of body—systemic scleroderma	0.00234	0.0139	CbGeAlD
Aripiprazole—H1F0—connective tissue—systemic scleroderma	0.00223	0.0133	CbGeAlD
Aripiprazole—HTR2A—artery—systemic scleroderma	0.00215	0.0128	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—systemic scleroderma	0.00204	0.0122	CbGeAlD
Aripiprazole—H1F0—skin of body—systemic scleroderma	0.00201	0.012	CbGeAlD
Aripiprazole—HTR2A—endothelium—systemic scleroderma	0.00182	0.0108	CbGeAlD
Aripiprazole—HTR1D—connective tissue—systemic scleroderma	0.00173	0.0103	CbGeAlD
Aripiprazole—ADRB1—connective tissue—systemic scleroderma	0.00168	0.01	CbGeAlD
Aripiprazole—HTR2A—blood vessel—systemic scleroderma	0.00167	0.00998	CbGeAlD
Aripiprazole—H1F0—digestive system—systemic scleroderma	0.00161	0.0096	CbGeAlD
Aripiprazole—HTR3A—digestive system—systemic scleroderma	0.00154	0.00916	CbGeAlD
Aripiprazole—H1F0—tendon—systemic scleroderma	0.00153	0.00914	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—systemic scleroderma	0.00147	0.00876	CbGeAlD
Aripiprazole—HTR2B—skin of body—systemic scleroderma	0.00145	0.00865	CbGeAlD
Aripiprazole—HTR7—connective tissue—systemic scleroderma	0.00138	0.0082	CbGeAlD
Aripiprazole—H1F0—lung—systemic scleroderma	0.00135	0.00802	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—systemic scleroderma	0.00132	0.00788	CbGeAlD
Aripiprazole—HTR3A—lung—systemic scleroderma	0.00128	0.00765	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—systemic scleroderma	0.00126	0.00751	CbGeAlD
Aripiprazole—SLC6A4—digestive system—systemic scleroderma	0.00117	0.00698	CbGeAlD
Aripiprazole—HTR2B—digestive system—systemic scleroderma	0.00116	0.00692	CbGeAlD
Aripiprazole—HTR2B—tendon—systemic scleroderma	0.00111	0.00659	CbGeAlD
Aripiprazole—ABCB1—blood vessel—systemic scleroderma	0.0011	0.00654	CbGeAlD
Aripiprazole—CHRM3—digestive system—systemic scleroderma	0.00104	0.00623	CbGeAlD
Aripiprazole—HRH1—connective tissue—systemic scleroderma	0.00103	0.00613	CbGeAlD
Aripiprazole—ADRB1—lung—systemic scleroderma	0.00101	0.00604	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—systemic scleroderma	0.00101	0.00602	CbGeAlD
Aripiprazole—HTR7—digestive system—systemic scleroderma	0.000994	0.00593	CbGeAlD
Aripiprazole—SLC6A4—lung—systemic scleroderma	0.000979	0.00583	CbGeAlD
Aripiprazole—CHRM1—lung—systemic scleroderma	0.000975	0.00581	CbGeAlD
Aripiprazole—HTR2B—lung—systemic scleroderma	0.00097	0.00578	CbGeAlD
Aripiprazole—HTR7—tendon—systemic scleroderma	0.000946	0.00564	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—systemic scleroderma	0.00094	0.0056	CbGeAlD
Aripiprazole—ADRA2C—tendon—systemic scleroderma	0.00087	0.00518	CbGeAlD
Aripiprazole—HTR2A—connective tissue—systemic scleroderma	0.000858	0.00512	CbGeAlD
Aripiprazole—HTR7—lung—systemic scleroderma	0.00083	0.00495	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—systemic scleroderma	0.000785	0.00468	CbGeAlD
Aripiprazole—DRD2—lung—systemic scleroderma	0.000785	0.00468	CbGeAlD
Aripiprazole—CYP3A5—digestive system—systemic scleroderma	0.000765	0.00456	CbGeAlD
Aripiprazole—ADRA2C—lung—systemic scleroderma	0.000763	0.00455	CbGeAlD
Aripiprazole—HRH1—digestive system—systemic scleroderma	0.000742	0.00442	CbGeAlD
Aripiprazole—HRH1—tendon—systemic scleroderma	0.000707	0.00421	CbGeAlD
Aripiprazole—ADRA2A—tendon—systemic scleroderma	0.000694	0.00414	CbGeAlD
Aripiprazole—CYP3A5—lung—systemic scleroderma	0.000639	0.00381	CbGeAlD
Aripiprazole—HTR2A—digestive system—systemic scleroderma	0.00062	0.0037	CbGeAlD
Aripiprazole—HRH1—lung—systemic scleroderma	0.00062	0.0037	CbGeAlD
Aripiprazole—ADRA2A—lung—systemic scleroderma	0.000609	0.00363	CbGeAlD
Aripiprazole—HTR2A—tendon—systemic scleroderma	0.00059	0.00352	CbGeAlD
Aripiprazole—CYP3A4—digestive system—systemic scleroderma	0.000574	0.00342	CbGeAlD
Aripiprazole—CYP2D6—digestive system—systemic scleroderma	0.000565	0.00337	CbGeAlD
Aripiprazole—HTR2A—lung—systemic scleroderma	0.000518	0.00309	CbGeAlD
Aripiprazole—ABCB1—digestive system—systemic scleroderma	0.000406	0.00242	CbGeAlD
Aripiprazole—ABCB1—lung—systemic scleroderma	0.000339	0.00202	CbGeAlD
Aripiprazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000159	0.000249	CcSEcCtD
Aripiprazole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000249	CcSEcCtD
Aripiprazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000158	0.000248	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000158	0.000248	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000248	CcSEcCtD
Aripiprazole—Insomnia—Lisinopril—systemic scleroderma	0.000157	0.000247	CcSEcCtD
Aripiprazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000247	CcSEcCtD
Aripiprazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000156	0.000246	CcSEcCtD
Aripiprazole—Vomiting—Captopril—systemic scleroderma	0.000156	0.000246	CcSEcCtD
Aripiprazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000244	CcSEcCtD
Aripiprazole—Dyspnoea—Lisinopril—systemic scleroderma	0.000155	0.000244	CcSEcCtD
Aripiprazole—Rash—Captopril—systemic scleroderma	0.000155	0.000243	CcSEcCtD
Aripiprazole—Dermatitis—Captopril—systemic scleroderma	0.000155	0.000243	CcSEcCtD
Aripiprazole—Somnolence—Lisinopril—systemic scleroderma	0.000155	0.000243	CcSEcCtD
Aripiprazole—Headache—Captopril—systemic scleroderma	0.000154	0.000242	CcSEcCtD
Aripiprazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000242	CcSEcCtD
Aripiprazole—Dyspepsia—Lisinopril—systemic scleroderma	0.000153	0.000241	CcSEcCtD
Aripiprazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000153	0.00024	CcSEcCtD
Aripiprazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000153	0.00024	CcSEcCtD
Aripiprazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00024	CcSEcCtD
Aripiprazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00024	CcSEcCtD
Aripiprazole—Asthma—Methotrexate—systemic scleroderma	0.000152	0.000239	CcSEcCtD
Aripiprazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000238	CcSEcCtD
Aripiprazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000151	0.000238	CcSEcCtD
Aripiprazole—Eosinophilia—Methotrexate—systemic scleroderma	0.00015	0.000236	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00015	0.000236	CcSEcCtD
Aripiprazole—Fatigue—Lisinopril—systemic scleroderma	0.00015	0.000236	CcSEcCtD
Aripiprazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000236	CcSEcCtD
Aripiprazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000235	CcSEcCtD
Aripiprazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000235	CcSEcCtD
Aripiprazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000149	0.000234	CcSEcCtD
Aripiprazole—Pancreatitis—Methotrexate—systemic scleroderma	0.000149	0.000234	CcSEcCtD
Aripiprazole—Pain—Lisinopril—systemic scleroderma	0.000149	0.000234	CcSEcCtD
Aripiprazole—Constipation—Lisinopril—systemic scleroderma	0.000149	0.000234	CcSEcCtD
Aripiprazole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000234	CcSEcCtD
Aripiprazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000233	CcSEcCtD
Aripiprazole—Bradycardia—Prednisone—systemic scleroderma	0.000148	0.000233	CcSEcCtD
Aripiprazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000232	CcSEcCtD
Aripiprazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000147	0.000231	CcSEcCtD
Aripiprazole—Haemoglobin—Prednisone—systemic scleroderma	0.000146	0.00023	CcSEcCtD
Aripiprazole—Nausea—Captopril—systemic scleroderma	0.000146	0.000229	CcSEcCtD
Aripiprazole—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000146	0.000229	CcSEcCtD
Aripiprazole—Haemorrhage—Prednisone—systemic scleroderma	0.000145	0.000229	CcSEcCtD
Aripiprazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000228	CcSEcCtD
Aripiprazole—Asthenia—Leflunomide—systemic scleroderma	0.000145	0.000228	CcSEcCtD
Aripiprazole—Hallucination—Prednisone—systemic scleroderma	0.000145	0.000227	CcSEcCtD
Aripiprazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000143	0.000225	CcSEcCtD
Aripiprazole—Pruritus—Leflunomide—systemic scleroderma	0.000143	0.000225	CcSEcCtD
Aripiprazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000143	0.000225	CcSEcCtD
Aripiprazole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000224	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000142	0.000224	CcSEcCtD
Aripiprazole—Dysuria—Methotrexate—systemic scleroderma	0.000142	0.000223	CcSEcCtD
Aripiprazole—Neutropenia—Methotrexate—systemic scleroderma	0.000142	0.000223	CcSEcCtD
Aripiprazole—Dizziness—Azathioprine—systemic scleroderma	0.000142	0.000223	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000141	0.000222	CcSEcCtD
Aripiprazole—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00014	0.00022	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000218	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000139	0.000218	CcSEcCtD
Aripiprazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000139	0.000218	CcSEcCtD
Aripiprazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000139	0.000218	CcSEcCtD
Aripiprazole—Urticaria—Lisinopril—systemic scleroderma	0.000138	0.000217	CcSEcCtD
Aripiprazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000217	CcSEcCtD
Aripiprazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000138	0.000216	CcSEcCtD
Aripiprazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000138	0.000216	CcSEcCtD
Aripiprazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000215	CcSEcCtD
Aripiprazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000137	0.000215	CcSEcCtD
Aripiprazole—Vomiting—Azathioprine—systemic scleroderma	0.000136	0.000214	CcSEcCtD
Aripiprazole—Pneumonia—Methotrexate—systemic scleroderma	0.000136	0.000214	CcSEcCtD
Aripiprazole—Eye disorder—Prednisone—systemic scleroderma	0.000136	0.000214	CcSEcCtD
Aripiprazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000214	CcSEcCtD
Aripiprazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000213	CcSEcCtD
Aripiprazole—Infestation—Methotrexate—systemic scleroderma	0.000135	0.000213	CcSEcCtD
Aripiprazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000135	0.000213	CcSEcCtD
Aripiprazole—Rash—Azathioprine—systemic scleroderma	0.000135	0.000212	CcSEcCtD
Aripiprazole—Dermatitis—Azathioprine—systemic scleroderma	0.000135	0.000212	CcSEcCtD
Aripiprazole—Depression—Methotrexate—systemic scleroderma	0.000135	0.000212	CcSEcCtD
Aripiprazole—Flushing—Prednisone—systemic scleroderma	0.000135	0.000212	CcSEcCtD
Aripiprazole—Headache—Azathioprine—systemic scleroderma	0.000134	0.000211	CcSEcCtD
Aripiprazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000211	CcSEcCtD
Aripiprazole—Dizziness—Leflunomide—systemic scleroderma	0.000134	0.00021	CcSEcCtD
Aripiprazole—Renal failure—Methotrexate—systemic scleroderma	0.000133	0.000209	CcSEcCtD
Aripiprazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000208	CcSEcCtD
Aripiprazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000132	0.000208	CcSEcCtD
Aripiprazole—Stomatitis—Methotrexate—systemic scleroderma	0.000132	0.000207	CcSEcCtD
Aripiprazole—Angiopathy—Prednisone—systemic scleroderma	0.000132	0.000207	CcSEcCtD
Aripiprazole—Conjunctivitis—Methotrexate—systemic scleroderma	0.000132	0.000207	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000207	CcSEcCtD
Aripiprazole—Immune system disorder—Prednisone—systemic scleroderma	0.000131	0.000206	CcSEcCtD
Aripiprazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000205	CcSEcCtD
Aripiprazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000205	CcSEcCtD
Aripiprazole—Sweating—Methotrexate—systemic scleroderma	0.00013	0.000204	CcSEcCtD
Aripiprazole—Haematuria—Methotrexate—systemic scleroderma	0.000129	0.000203	CcSEcCtD
Aripiprazole—Vomiting—Leflunomide—systemic scleroderma	0.000129	0.000202	CcSEcCtD
Aripiprazole—Alopecia—Prednisone—systemic scleroderma	0.000129	0.000202	CcSEcCtD
Aripiprazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000128	0.000201	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000128	0.000201	CcSEcCtD
Aripiprazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000128	0.000201	CcSEcCtD
Aripiprazole—Epistaxis—Methotrexate—systemic scleroderma	0.000128	0.000201	CcSEcCtD
Aripiprazole—Rash—Leflunomide—systemic scleroderma	0.000128	0.000201	CcSEcCtD
Aripiprazole—Dermatitis—Leflunomide—systemic scleroderma	0.000128	0.0002	CcSEcCtD
Aripiprazole—Mental disorder—Prednisone—systemic scleroderma	0.000127	0.0002	CcSEcCtD
Aripiprazole—Nausea—Azathioprine—systemic scleroderma	0.000127	0.0002	CcSEcCtD
Aripiprazole—Headache—Leflunomide—systemic scleroderma	0.000127	0.000199	CcSEcCtD
Aripiprazole—Malnutrition—Prednisone—systemic scleroderma	0.000127	0.000199	CcSEcCtD
Aripiprazole—Erythema—Prednisone—systemic scleroderma	0.000127	0.000199	CcSEcCtD
Aripiprazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000126	0.000199	CcSEcCtD
Aripiprazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000197	CcSEcCtD
Aripiprazole—Asthenia—Lisinopril—systemic scleroderma	0.000125	0.000196	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000196	CcSEcCtD
Aripiprazole—Pruritus—Lisinopril—systemic scleroderma	0.000123	0.000193	CcSEcCtD
Aripiprazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000123	0.000193	CcSEcCtD
Aripiprazole—Haemoglobin—Methotrexate—systemic scleroderma	0.000122	0.000192	CcSEcCtD
Aripiprazole—Rash—Mycophenolic acid—systemic scleroderma	0.000122	0.000191	CcSEcCtD
Aripiprazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000122	0.000191	CcSEcCtD
Aripiprazole—Haemorrhage—Methotrexate—systemic scleroderma	0.000122	0.000191	CcSEcCtD
Aripiprazole—Hepatitis—Methotrexate—systemic scleroderma	0.000122	0.000191	CcSEcCtD
Aripiprazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00019	CcSEcCtD
Aripiprazole—Headache—Mycophenolic acid—systemic scleroderma	0.000121	0.00019	CcSEcCtD
Aripiprazole—Pharyngitis—Methotrexate—systemic scleroderma	0.000121	0.00019	CcSEcCtD
Aripiprazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000189	CcSEcCtD
Aripiprazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000189	CcSEcCtD
Aripiprazole—Nausea—Leflunomide—systemic scleroderma	0.00012	0.000189	CcSEcCtD
Aripiprazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00012	0.000189	CcSEcCtD
Aripiprazole—Vision blurred—Prednisone—systemic scleroderma	0.000119	0.000188	CcSEcCtD
Aripiprazole—Urethral disorder—Methotrexate—systemic scleroderma	0.000119	0.000187	CcSEcCtD
Aripiprazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000119	0.000187	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000117	0.000185	CcSEcCtD
Aripiprazole—Visual impairment—Methotrexate—systemic scleroderma	0.000117	0.000184	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—systemic scleroderma	0.000117	0.000184	CcSEcCtD
Aripiprazole—Agitation—Prednisone—systemic scleroderma	0.000116	0.000183	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—systemic scleroderma	0.000116	0.000182	CcSEcCtD
Aripiprazole—Dizziness—Lisinopril—systemic scleroderma	0.000115	0.000181	CcSEcCtD
Aripiprazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000115	0.00018	CcSEcCtD
Aripiprazole—Malaise—Prednisone—systemic scleroderma	0.000114	0.000179	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—systemic scleroderma	0.000114	0.000179	CcSEcCtD
Aripiprazole—Eye disorder—Methotrexate—systemic scleroderma	0.000114	0.000179	CcSEcCtD
Aripiprazole—Syncope—Prednisone—systemic scleroderma	0.000114	0.000178	CcSEcCtD
Aripiprazole—Tinnitus—Methotrexate—systemic scleroderma	0.000113	0.000178	CcSEcCtD
Aripiprazole—Cardiac disorder—Methotrexate—systemic scleroderma	0.000113	0.000177	CcSEcCtD
Aripiprazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000177	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—systemic scleroderma	0.000111	0.000175	CcSEcCtD
Aripiprazole—Vomiting—Lisinopril—systemic scleroderma	0.000111	0.000174	CcSEcCtD
Aripiprazole—Angiopathy—Methotrexate—systemic scleroderma	0.00011	0.000173	CcSEcCtD
Aripiprazole—Immune system disorder—Methotrexate—systemic scleroderma	0.00011	0.000173	CcSEcCtD
Aripiprazole—Rash—Lisinopril—systemic scleroderma	0.00011	0.000172	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—systemic scleroderma	0.00011	0.000172	CcSEcCtD
Aripiprazole—Dermatitis—Lisinopril—systemic scleroderma	0.00011	0.000172	CcSEcCtD
Aripiprazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00011	0.000172	CcSEcCtD
Aripiprazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000172	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—systemic scleroderma	0.000109	0.000172	CcSEcCtD
Aripiprazole—Chills—Methotrexate—systemic scleroderma	0.000109	0.000171	CcSEcCtD
Aripiprazole—Headache—Lisinopril—systemic scleroderma	0.000109	0.000171	CcSEcCtD
Aripiprazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000108	0.00017	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—systemic scleroderma	0.000108	0.000169	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—systemic scleroderma	0.000108	0.000169	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—systemic scleroderma	0.000107	0.000169	CcSEcCtD
Aripiprazole—Alopecia—Methotrexate—systemic scleroderma	0.000107	0.000169	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000107	0.000168	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—systemic scleroderma	0.000107	0.000167	CcSEcCtD
Aripiprazole—Mental disorder—Methotrexate—systemic scleroderma	0.000106	0.000167	CcSEcCtD
Aripiprazole—Malnutrition—Methotrexate—systemic scleroderma	0.000106	0.000166	CcSEcCtD
Aripiprazole—Erythema—Methotrexate—systemic scleroderma	0.000106	0.000166	CcSEcCtD
Aripiprazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000164	CcSEcCtD
Aripiprazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000104	0.000163	CcSEcCtD
Aripiprazole—Nausea—Lisinopril—systemic scleroderma	0.000103	0.000162	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000103	0.000162	CcSEcCtD
Aripiprazole—Oedema—Prednisone—systemic scleroderma	0.000103	0.000162	CcSEcCtD
Aripiprazole—Infection—Prednisone—systemic scleroderma	0.000103	0.000161	CcSEcCtD
Aripiprazole—Back pain—Methotrexate—systemic scleroderma	0.000102	0.000161	CcSEcCtD
Aripiprazole—Shock—Prednisone—systemic scleroderma	0.000102	0.00016	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000101	0.000159	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—systemic scleroderma	0.000101	0.000159	CcSEcCtD
Aripiprazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000158	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—systemic scleroderma	0.0001	0.000158	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—systemic scleroderma	9.99e-05	0.000157	CcSEcCtD
Aripiprazole—Vision blurred—Methotrexate—systemic scleroderma	9.97e-05	0.000157	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—systemic scleroderma	9.85e-05	0.000155	CcSEcCtD
Aripiprazole—Ill-defined disorder—Methotrexate—systemic scleroderma	9.82e-05	0.000154	CcSEcCtD
Aripiprazole—Anaemia—Methotrexate—systemic scleroderma	9.78e-05	0.000154	CcSEcCtD
Aripiprazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.69e-05	0.000152	CcSEcCtD
Aripiprazole—Rash—Mycophenolate mofetil—systemic scleroderma	9.61e-05	0.000151	CcSEcCtD
Aripiprazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.6e-05	0.000151	CcSEcCtD
Aripiprazole—Headache—Mycophenolate mofetil—systemic scleroderma	9.55e-05	0.00015	CcSEcCtD
Aripiprazole—Malaise—Methotrexate—systemic scleroderma	9.54e-05	0.00015	CcSEcCtD
Aripiprazole—Vertigo—Methotrexate—systemic scleroderma	9.51e-05	0.000149	CcSEcCtD
Aripiprazole—Leukopenia—Methotrexate—systemic scleroderma	9.47e-05	0.000149	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.41e-05	0.000148	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—systemic scleroderma	9.35e-05	0.000147	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—systemic scleroderma	9.28e-05	0.000146	CcSEcCtD
Aripiprazole—Cough—Methotrexate—systemic scleroderma	9.23e-05	0.000145	CcSEcCtD
Aripiprazole—Convulsion—Methotrexate—systemic scleroderma	9.17e-05	0.000144	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—systemic scleroderma	9.1e-05	0.000143	CcSEcCtD
Aripiprazole—Nausea—Mycophenolate mofetil—systemic scleroderma	9.06e-05	0.000142	CcSEcCtD
Aripiprazole—Myalgia—Methotrexate—systemic scleroderma	9.01e-05	0.000142	CcSEcCtD
Aripiprazole—Chest pain—Methotrexate—systemic scleroderma	9.01e-05	0.000142	CcSEcCtD
Aripiprazole—Arthralgia—Methotrexate—systemic scleroderma	9.01e-05	0.000142	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—systemic scleroderma	8.98e-05	0.000141	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.95e-05	0.000141	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—systemic scleroderma	8.91e-05	0.00014	CcSEcCtD
Aripiprazole—Discomfort—Methotrexate—systemic scleroderma	8.9e-05	0.00014	CcSEcCtD
Aripiprazole—Constipation—Prednisone—systemic scleroderma	8.84e-05	0.000139	CcSEcCtD
Aripiprazole—Confusional state—Methotrexate—systemic scleroderma	8.71e-05	0.000137	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methotrexate—systemic scleroderma	8.64e-05	0.000136	CcSEcCtD
Aripiprazole—Infection—Methotrexate—systemic scleroderma	8.58e-05	0.000135	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—systemic scleroderma	8.52e-05	0.000134	CcSEcCtD
Aripiprazole—Nervous system disorder—Methotrexate—systemic scleroderma	8.47e-05	0.000133	CcSEcCtD
Aripiprazole—Thrombocytopenia—Methotrexate—systemic scleroderma	8.46e-05	0.000133	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—systemic scleroderma	8.45e-05	0.000133	CcSEcCtD
Aripiprazole—Skin disorder—Methotrexate—systemic scleroderma	8.39e-05	0.000132	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methotrexate—systemic scleroderma	8.35e-05	0.000131	CcSEcCtD
Aripiprazole—Anorexia—Methotrexate—systemic scleroderma	8.23e-05	0.000129	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—systemic scleroderma	8.21e-05	0.000129	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—systemic scleroderma	8.17e-05	0.000128	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—systemic scleroderma	8.17e-05	0.000128	CcSEcCtD
Aripiprazole—Hypotension—Methotrexate—systemic scleroderma	8.07e-05	0.000127	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.87e-05	0.000124	CcSEcCtD
Aripiprazole—Insomnia—Methotrexate—systemic scleroderma	7.81e-05	0.000123	CcSEcCtD
Aripiprazole—Paraesthesia—Methotrexate—systemic scleroderma	7.75e-05	0.000122	CcSEcCtD
Aripiprazole—Dyspnoea—Methotrexate—systemic scleroderma	7.7e-05	0.000121	CcSEcCtD
Aripiprazole—Somnolence—Methotrexate—systemic scleroderma	7.68e-05	0.000121	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—systemic scleroderma	7.61e-05	0.00012	CcSEcCtD
Aripiprazole—Dyspepsia—Methotrexate—systemic scleroderma	7.6e-05	0.000119	CcSEcCtD
Aripiprazole—Decreased appetite—Methotrexate—systemic scleroderma	7.51e-05	0.000118	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.46e-05	0.000117	CcSEcCtD
Aripiprazole—Fatigue—Methotrexate—systemic scleroderma	7.45e-05	0.000117	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—systemic scleroderma	7.41e-05	0.000117	CcSEcCtD
Aripiprazole—Pain—Methotrexate—systemic scleroderma	7.39e-05	0.000116	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—systemic scleroderma	7.31e-05	0.000115	CcSEcCtD
Aripiprazole—Feeling abnormal—Methotrexate—systemic scleroderma	7.12e-05	0.000112	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—systemic scleroderma	7.07e-05	0.000111	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.06e-05	0.000111	CcSEcCtD
Aripiprazole—Urticaria—Methotrexate—systemic scleroderma	6.86e-05	0.000108	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—systemic scleroderma	6.83e-05	0.000107	CcSEcCtD
Aripiprazole—Body temperature increased—Methotrexate—systemic scleroderma	6.83e-05	0.000107	CcSEcCtD
Aripiprazole—Abdominal pain—Methotrexate—systemic scleroderma	6.83e-05	0.000107	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—systemic scleroderma	6.57e-05	0.000103	CcSEcCtD
Aripiprazole—Rash—Prednisone—systemic scleroderma	6.52e-05	0.000102	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—systemic scleroderma	6.51e-05	0.000102	CcSEcCtD
Aripiprazole—Headache—Prednisone—systemic scleroderma	6.47e-05	0.000102	CcSEcCtD
Aripiprazole—Hypersensitivity—Methotrexate—systemic scleroderma	6.36e-05	0.0001	CcSEcCtD
Aripiprazole—Asthenia—Methotrexate—systemic scleroderma	6.2e-05	9.74e-05	CcSEcCtD
Aripiprazole—Nausea—Prednisone—systemic scleroderma	6.14e-05	9.65e-05	CcSEcCtD
Aripiprazole—Pruritus—Methotrexate—systemic scleroderma	6.11e-05	9.6e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Methotrexate—systemic scleroderma	5.91e-05	9.29e-05	CcSEcCtD
Aripiprazole—Dizziness—Methotrexate—systemic scleroderma	5.71e-05	8.98e-05	CcSEcCtD
Aripiprazole—Vomiting—Methotrexate—systemic scleroderma	5.49e-05	8.63e-05	CcSEcCtD
Aripiprazole—Rash—Methotrexate—systemic scleroderma	5.45e-05	8.56e-05	CcSEcCtD
Aripiprazole—Dermatitis—Methotrexate—systemic scleroderma	5.44e-05	8.55e-05	CcSEcCtD
Aripiprazole—Headache—Methotrexate—systemic scleroderma	5.41e-05	8.5e-05	CcSEcCtD
Aripiprazole—Nausea—Methotrexate—systemic scleroderma	5.13e-05	8.06e-05	CcSEcCtD
